查詢結果分析
來源資料
相關文獻
- 多重抗藥性淋病的診斷治療與衍生的倫理問題
- Prevalence of Chlamydia Trachomatis Infections among Selected Populations in a Community Hospital in Taiwan
- 百合潛隱性病毒病害之鑑定及診斷
- 性病介紹之2--淋病
- 愛滋病及梅毒以外之其他性病診斷與治療
- 常見性病的診斷與治療
- 中風合併低血鈉病人的居家照護經驗:個案報告
- Medical Ethics Education: World Trends and the Harvard Experience
- Implementation of Medical Ethics Education
- 彰化地區老人的慢性病罹患狀況與醫療服務需求
頁籤選單縮合
題 名 | 多重抗藥性淋病的診斷治療與衍生的倫理問題=Diagnosis, Therapy, and Ethical Issues in the Treatment of Multidrug Resistant Neisseria Gonorrhoeae |
---|---|
作 者 | 黃信陽; 陳彥元; 江宜勳; 梁繼權; | 書刊名 | 臺灣家庭醫學雜誌 |
卷 期 | 20:3 2010.09[民99.09] |
頁 次 | 頁145-151 |
分類號 | 415.2732 |
關鍵詞 | 淋病; 性病; 醫學倫理; Gonorrhea; Quinolone resistance; Sexually transmitted disease; Expedited treatment; Medical ethics; |
語 文 | 中文(Chinese) |
中文摘要 | 淋病屬第三類法定傳染病,大部分皆在基層診所診斷治療。過去對penicillin類及quinolone抗藥性問題不斷浮現,在東亞地區quinolone抗藥性的比例達80%以上,2006年美國疾病管制局不建議使用fluoroquinolone治療淋病。在台灣ceftriaxone目前可有效根除泌尿生殖道淋病感染。本文報告二位ciprofloxacin抗藥性淋病尿道炎的年輕男性診斷與治療過程,也討論性伴侶的治療與衍生的倫理議題和法律爭議。 |
英文摘要 | Gonorrhea, usually diagnosed and treated in primary care clinics, is classified as a third-category notifiable infectious diseases which requires mandatory reporting to the Taiwan Centers for Disease Control. In East Asia, as well as in Taiwan, up to 80% of gonorrheal cases are quinolone-resistant. Due to the increasing number of cases of penicillin-resistant or quinolone-resistant gonorrhea, the United States Centers for Disease Control and Prevention stopped suggesting treating gonorrhea with fluoroquinolone in 2006. In this paper, we report the cases of two young male adults with ciprofloxacin-resistant gonorrheal urethritis. One of them was initially treated with fluoroquinolone and was a treatment failure. Changing the antibiotic to ceftriaxone eventually resulted in treatment success. The other case was lost to follow-up after the diagnosis was confirmed and treatment with ceftriaxone was started. Although expedited treatment is a very important strategy for treating gonorrhea, physicians in primary care clinics in Taiwan still encounter dilemmas due to legal and ethical concerns when employing this strategy. |
本系統中英文摘要資訊取自各篇刊載內容。